TD Asset Management
MIRM icon

TD Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

TD Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.77M Buy
54,478
+14,590
+37% +$1.52M ﹤0.01% 797
2026
Q2 		$4.67M Buy
39,888
+6,200
+18% +$622K ﹤0.01% 817
2026
Q1 		$3.11M Buy
33,688
+10,412
+45% +$979K ﹤0.01% 877
2025
Q4 		$1.84M Buy
23,276
+7,876
+51% +$565K ﹤0.01% 1005
2025
Q3 		$1.13M Buy
+15,400
New +$979K ﹤0.01% 1069
2024
Q2 		– Sell
-59,800
Closed -$1.5M – 1400
2024
Q1 		$1.5M Buy
59,800
+12,800
+27% +$352K ﹤0.01% 1094
2023
Q4 		$1.39M Buy
+47,000
New +$1.42M ﹤0.01% 1108

Other funds holding MIRM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

TD Asset Management's MIRM Position: Q3 2026 in Review

TD Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 37% in Q3 2026, buying an estimated $1.52M and bringing the position to 54,478 shares worth $4.77M. The position accounts for ﹤0.01% of the portfolio, ranked #797.

TD Asset Management first reported a position in MIRM in Q4 2023 and has held it in 7 quarters since. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • TD Asset Management held 54,478 shares of Mirum Pharmaceuticals worth $4.77M as of Q3 2026.
  • TD Asset Management bought 14,590 Mirum Pharmaceuticals shares in Q3 2026, an estimated $1.52M.
  • Mirum Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q3 2026, its #797 holding.
  • TD Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.